Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 1, 2009, Pages 99-107

  Birukova, Anna A ^a   Cokic, Ivan ^a   Moldobaeva, Nurgul ^a   Birukov, Konstantin G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Growth factors; Paxillin; Permeability; Pulmonary endothelium; Small GTPase

Indexed keywords

FOCAL ADHESION KINASE; MYOSIN LIGHT CHAIN; P21 ACTIVATED KINASE 1; PAXILLIN; RAC PROTEIN; RHO FACTOR; SCATTER FACTOR; SMALL INTERFERING RNA; VASCULOTROPIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULOTROPIN A;

ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FOCAL ADHESION; HUMAN; HUMAN CELL; LUNG ENDOTHELIUM; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRESS FIBER; ANIMAL; CYTOLOGY; GENE SILENCING; GENETICS; IMPEDANCE; METABOLISM; PERMEABILITY;

ANIMALS; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; FOCAL ADHESIONS; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HUMANS; PAXILLIN; PERMEABILITY; RAC GTP-BINDING PROTEINS; RHO GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149356253     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0099OC     Document Type: Article

References (53)

1. Dvorak HF. Discovery of vascular permeability factor (VPF). Exp Cell Res 2006;312:522-526.
2. akahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 2005;109:227-241.
3. Choi WI, Quinn DA, Park KM, Moufarrej RK, Jafari B, Syrkina O, Bonventre JV, Hales CA. Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am J Respir Crit Care Med 2003;167:1627-1632.
4. Medford AR, Millar AB. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 2006;61:621-626.
5. Mura M, dos Santos CC, Stewart D, Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. JAppl Physiol 2004;97:1605-1617.
6. Becker PM, Verin AD, Booth MA, Liu F, Birukova A, Garcia JG. Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001;281:L1500-L1511.
7. Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 2002;39:187-199.
8. Sun H, Breslin JW, Zhu J, Yuan SY, Wu MH. Rho and rock signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 2006;13:237-247.
9. Morimoto K, Amano H, Sonoda F, Baba M, Senba M, Yoshimine H, Yamamoto H, Ii T, Oishi K, Nagatake T. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol 2001;24:608-615.
10. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993;268:21212-21217.
11. Vivekananda J, Awasthi V, Awasthi S, Smith DB, King RJ. Hepatocyte growth factor is elevated in chronic lung injury and inhibits surfactant metabolism. Am J Physiol Lung Cell Mol Physiol 2000;278:L382- L392.
12. Tomita N, Morishita R, Higaki J, Ogihara T. Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factor. J Atheroscler Thromb 2000;7:1-7.
13. Lesko E, Majka M. The biological role of HGF-met axis in tumor growth and development of metastasis. Front Biosci 2008;13:1271-1280.
14. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. Sphingosine 1-phosphate promotes endo- thelial cell barrier integrity by edg-dependent cytoskeletal rearrangement. J Clin Invest 2001;108:689-701.
15. Date I, Takagi N, Takagi K, Kago T, Matsumoto K, Nakamura T, Takeo S. Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction. Biochem Biophys Res Commun 2004;319:1152-1158.
16. Liu F, Schaphorst KL, Verin AD, Jacobs K, Birukova A, Day RM, Bogatcheva N, Bottaro DP, Garcia JG. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J 2002;16:950-962.
17. Singleton PA, Salgia R, Moreno-Vinasco L, Moitra J, Sammani S, Mirzapoiazova T, Garcia JG. CD44 regulates hepatocyte growth factor-mediated vascular integrity: role of c-met, tiam1/Rac1, dynamin 2, and cortactin. J Biol Chem 2007;282:30643-30657.
18. Birukova AA, Alekseeva E, Mikaelyan A, Birukov KG. HGF attenuates thrombin-induced permeability in the human pulmonary endothelial cells by tiam1-mediated activation of the Rac pathway and by tiam1/Rac-dependent inhibition of the rho pathway. FASEB J 2007;21:2776-2786.
19. Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002;282:L924-L940.
20. Han B, Lodyga M, Liu M. Ventilator-induced lung injury: role of protein-protein interaction in mechanosensation. Proc Am Thorac Soc 2005;2:181-187.
21. Birukov KG, Birukova AA, Dudek SM, Verin AD, Crow MT, Zhan X, DePaola N, Garcia JG. Shear stress-mediated cytoskeletal remodeling and cortactin translocation in pulmonary endothelial cells. Am J Respir Cell Mol Biol 2002;26:453-464.
22. Shikata Y, Birukov KG, Garcia JG. S1p induces FA remodeling in human pulmonary endothelial cells: Role of Rac, git1, fak and paxillin. J Appl Physiol 2003;94:1193-1203.
23. Shikata Y, Birukov KG, Birukova AA, Verin AD, Garcia JG. Involvement of site-specific fak phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of src and git. FASEB J 2003;17:2240-2249.
24. Shikata Y, Rios A, Kawkitinarong K, DePaola N, Garcia JG, Birukov KG. Differential effects of shear stress and cyclic stretch on focal adhesion remodeling, site-specific FAK phosphorylation, and small GTPases in human lung endothelial cells. Exp Cell Res 2005;304:40-49.
25. Birukova AA, Chatchavalvanich S, Rios A, Kawkitinarong K, Garcia JG, Birukov KG. Differential regulation of pulmonary endothelial monolayer integrity by varying degrees of cyclic stretch. Am J Pathol 2006;168:1749-1761.
26. Mehta D, Tiruppathi C, Sandoval R, Minshall RD, Holinstat M, Malik AB. Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier function. J Physiol 2002;539:779-789.
27. Holinstat M, Knezevic N, Broman M, Samarel AM, Malik AB, Mehta D. Suppression of rhoa activity by focal adhesion kinase-induced activation of p190rhogap: role in regulation of endothelial permeability. J Biol Chem 2006;281:2296-2305.
28. Turner CE. Paxillin. Int J Biochem Cell Biol 1998;30:955-959.
29. Brown MC, Turner CE. Paxillin: adapting to change. Physiol Rev 2004;84:1315-1339.
30. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6:56-68.
31. Iwasaki T, Nakata A, Mukai M, Shinkai K, Yano H, Sabe H, Schaefer E, Tatsuta M, Tsujimura T, Terada N, et al. Involvement of phosphorylation of tyr-31 and tyr-118 of paxillin in MM1 cancer cell migration. Int J Cancer 2002;97:330-335.
32. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2000;2:E231-E236.
33. Turner CE. Paxillin interactions. J Cell Sci 2000;113:4139-4140.
34. Nayal A, Webb DJ, Brown CM, Schaefer EM, Vicente-Manzanares M, Horwitz AR. Paxillin phosphorylation at ser273 localizes a git1-pixpak complex and regulates adhesion and protrusion dynamics. J Cell Biol 2006;173:587-599.
35. Verin AD, Birukova A, Wang P, Liu F, Becker P, Birukov K, Garcia JG. Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 2001;281:L565-L574.
36. Birukov KG, Bochkov VN, Birukova AA, Kawkitinarong K, Rios A, Leitner A, Verin AD, Bokoch GM, Leitinger N, Garcia JG. Epoxycyclopentenone-containing oxidized phospholipids restore en-dothelial barrier function via CDC42 and Rac. Circ Res 2004;95: 892-901.
37. Yano H, Mazaki Y, Kurokawa K, Hanks SK, Matsuda M, Sabe H. Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion. J Cell Biol 2004;166:283-295.
38. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JGN, Verin AD. Role of rho gtpases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 2004;67:64-77.
39. Birukova AA, Birukov KG, Smurova K, Adyshev DM, Kaibuchi K, Alieva I, Garcia JG, Verin AD. Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB J 2004;18:1879-1890.
40. Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW II, Duran WN. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 2003;284:H92-H100.
41. Schaller MD, Parsons JT. Pp125fak-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for crk. Mol Cell Biol 1995;15:2635-2645.
42. Bellis SL, Miller JT, Turner CE. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem 1995; 270:17437-17441.
43. Birukova AA, Malyukova I, Poroyko V, Birukov KG. Paxillin-betacatenin interactions are involved in Rac/CDC42-mediated endothelial barrier-protective response to oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 2007;293:L199-L211.
44. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, Garcia JG. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004;279:24692-24700.
45. Birukova AA, Zagranichnaya T, Alekseeva E, Fu P, Chen W, Jacobson JR, Birukov KG. Prostaglandins PGE2 and PGI2 promote endothe- lial barrier enhancement via PKA- and EPAC1/RAP1-dependent Rac activation. Exp Cell Res 2007;313:2504-2520.
46. Birukova AA, Malyukova I, Mikaelyan A, Fu P, Birukov KG. Tiam1 and betapix mediate rac-dependent endothelial barrier protective response to oxidized phospholipids. J Cell Physiol 2007;211:608-617.
47. Geiser T. Mechanisms of alveolar epithelial repair in acute lung injury: a translational approach. Swiss Med Wkly 2003;133:586-590.
48. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem (Tokyo) 1996;119:591-600.
49. Book AA, Ranganathan S, Abounader R, Rosen E, Laterra J. Scatter factor/hepatocyte growth factor gene transfer increases rat blood glioma barrier permeability. Brain Res 1999;833:173-180.
50. Martin TA, Mansel RE, Jiang WG. Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells. J Cell Physiol 2002;192:268-275.
51. Clermont AC, Cahill M, Salti H, Rook SL, Rask-Madsen C, Goddard L, Wong JS, Bursell D, Bursell SE, Aiello LP. Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Invest Ophthalmol Vis Sci 2006;47:2701-2708.
52. Van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 2003;23:211-217.
53. Brown MC, West KA, Turner CE. Paxillin-dependent paxillin kinase linker and p21-activated kinase localization to focal adhesions involves a multistep activation pathway. Mol Biol Cell 2002;13:1550-1565.